AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that just like Europe has stepped up its defence spending it now must do the same and invest more to protect its health sovereignty ...

Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder ...

AstraZeneca’s Pascal Soriot is no stranger to shareholder scrutiny—especially when it comes to the longtime CEO’s pay. But the latest campaign against his re-election is nothing short of ...

What Happened: Soriot made a significant move by purchasing 1,677 shares of Agilent Technologies as reported in a Form 4 filing with the U.S. Securities and Exchange Commission. The transaction's ...

AstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as the company tries to grab a slice of the booming weight-loss market and aims to almost double ...

Pascal Soriot, 65, fought off a takeover attempt of AstraZeneca Plc in the early stages of his 12-year run as chief executive officer before developing the company into a cancer drugs powerhouse ...

Pascal Soriot is CEO of pharmaceutical company AstraZeneca. As chair of the Sustainable Markets Initiative (SMI) Health System Task Force, Soriot brings together business leaders from across the ...

FRANKFURT (Reuters) - Long-serving AstraZeneca boss Pascal Soriot said on Friday he expects to work with the new chairman-designate of the London-listed drugmaker, who will take over in 2023 ...

In a Tuesday interview with CNBC's Jim Cramer, AstraZeneca CEO Pascal Soriot explained why the drugmaker believes it can almost double revenue by the end of the decade. AstraZeneca announced in ...

Is any employee worth paying £18.7m? That’s the monster sum AstraZeneca has awarded its chief executive, Pascal Soriot, who’s in line for a £1.5m salary with the rest in mostly share-based ...

Hello, everyone, and nice to see you again after our extended break. A little time away is always a good thing, but now we have returned to our usual routine. Of course, we are starting by firing ...

AstraZeneca’sAZN1.85%increase; green up pointing triangle longest-serving chief executive, Pascal Soriot, has no plans to step down for now as the company tries to grab a slice of the booming ...